283 related articles for article (PubMed ID: 10074499)
1. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
[TBL] [Abstract][Full Text] [Related]
2. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
[TBL] [Abstract][Full Text] [Related]
3. Use of CMV transcripts for monitoring of CMV infections in transplant recipients.
Gerna G; Baldanti F; Middeldorp J; Lilleri D
Int J Antimicrob Agents; 2000 Dec; 16(4):455-60. PubMed ID: 11118857
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.
Blok MJ; Goossens VJ; Vanherle SJ; Top B; Tacken N; Middeldorp JM; Christiaans MH; van Hooff JP; Bruggeman CA
J Clin Microbiol; 1998 May; 36(5):1341-6. PubMed ID: 9574702
[TBL] [Abstract][Full Text] [Related]
5. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
[TBL] [Abstract][Full Text] [Related]
6. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
[TBL] [Abstract][Full Text] [Related]
7. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification.
Greijer AE; Verschuuren EA; Harmsen MC; Dekkers CA; Adriaanse HM; The TH; Middeldorp JM
J Clin Microbiol; 2001 Jan; 39(1):251-9. PubMed ID: 11136779
[TBL] [Abstract][Full Text] [Related]
8. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.
Blok MJ; Lautenschlager I; Goossens VJ; Middeldorp JM; Vink C; Höckerstedt K; Bruggeman CA
J Clin Microbiol; 2000 Dec; 38(12):4485-91. PubMed ID: 11101584
[TBL] [Abstract][Full Text] [Related]
10. Preliminary report for the application of nucleic acid sequence-based amplification in detection of human cytomegalovirus (HCMV) late pp67 mRNA for diagnosis of HCMV infection.
Pairoj W; Srichunrusami C; Chantratita W; Bodhiphala P; Sungkanuparph S; Vibhagool A
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S28-34. PubMed ID: 10865403
[TBL] [Abstract][Full Text] [Related]
11. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
Goossens VJ; Blok MJ; Christiaans MH; van Hooff JP; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp JM; Bruggeman CA
Intervirology; 1999; 42(5-6):373-81. PubMed ID: 10702720
[TBL] [Abstract][Full Text] [Related]
13. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection.
Gerna G; Zavattoni M; Baldanti F; Sarasini A; Chezzi L; Grossi P; Revello MG
Transplantation; 1998 May; 65(10):1378-85. PubMed ID: 9625022
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.
Gerna G; Baldanti F; Lilleri D; Parea M; Torsellini M; Castiglioni B; Vitulo P; Pellegrini C; Viganò M; Grossi P; Revello MG
Transplantation; 2003 Apr; 75(7):1012-9. PubMed ID: 12698090
[TBL] [Abstract][Full Text] [Related]
18. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation.
Seehofer D; Meisel H; Rayes N; Stein A; Langrehr JM; Settmacher U; Neuhaus P
Am J Transplant; 2004 Aug; 4(8):1331-7. PubMed ID: 15268736
[TBL] [Abstract][Full Text] [Related]
20. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.
Witt DJ; Kemper M; Stead A; Sillekens P; Ginocchio CC; Espy MJ; Paya CV; Smith TF; Roeles F; Caliendo AM
J Clin Microbiol; 2000 Nov; 38(11):3994-9. PubMed ID: 11060058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
